| Stage | MAR | % of rev | MCRI | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $7.0B | 100.00% | $146M | 100.00% | MAR ×47.89 |
| Gross profit | $1.5B | 22.03% | $82M | 56.33% | MCRI +34.3pp |
| Operating income | $1.3B | 18.19% | $41M | 28.22% | MCRI +10.0pp |
| Pre-tax income | $1.1B | 15.13% | $42M | 28.79% | MCRI +13.7pp |
| Net income | $794M | 11.33% | $32M | 21.88% | MCRI +10.5pp |
| Stage | MAR | MCRI | Gap · A − B |
|---|---|---|---|
| Revenue | $7.0B100.00% | $146M100.00% | MAR ×47.89 |
| Gross profit | 22.03%$1.5B | 56.33%$82M | MCRI +34.3pp |
| Operating income | 18.19%$1.3B | 28.22%$41M | MCRI +10.0pp |
| Pre-tax income | 15.13%$1.1B | 28.79%$42M | MCRI +13.7pp |
| Net income |
| 11.33%$794M |
| 21.88%$32M |
| MCRI +10.5pp |
No disclosed counterparties: MCRI.
None